Capricor Therapeutics, Inc. Recorded Big Gain
Fri, Aug 14, 2026 at 07:34 PM
Capricor Therapeutics, Inc. (CAPR:NASDAQ) soared at $6.65, a gain of 58%. On Fri, Aug 14, 2026, CAPR:NASDAQ touched a New 2-Week High of $6.65. The stock got featured on our News Catalysts scanner on Fri, Aug 14, 2026 at 12:22 PM in the 'INVESTOR UPDATE' category. From Fri, Jul 31, 2026, the stock recorded 60.00% Up Days and 45.45% Green Days
The stock spiked on Mon, Apr 20, 2026 at $36.82 with a volume of 1M+.
About Capricor Therapeutics, Inc. (CAPR:NASDAQ)
Capricor Therapeutics Inc is a clinical stage biotechnology company developing products for the treatment of cardiovascular diseases with a focus on heart failure.
Top 10 Gainers:
- Webus International Limited (WETO:NASDAQ), 127.7%
- MDxHealth SA (MDXH:NASDAQ), 74.89%
- Capricor Therapeutics, Inc. (CAPR:NASDAQ), 57.96%
- CBL International Limited (BANL:NASDAQ), 55.92%
- Harte Hanks, Inc. (HHS:NASDAQ), 53.02%
- Movella Holdings Inc. (MVLA:NASDAQ), 50%
- VisionWave Holdings Inc. (VWAV:NASDAQ), 44.72%
- Eton Pharmaceuticals, Inc. (ETON:NASDAQ), 44.26%
- Digital Asset Acquisition Corp. (DAAQ:NASDAQ), 43.53%
- System1, Inc. (SST:NYSE), 38.24%